OEMs in pharma, chemistry, and biotech can no longer rely on hardware sales alone. Customers now expect equipment to come with digital layers such as monitoring dashboards, SaaS workflows, and compliance tools. The global digital lab market is projected to grow past $5B by 2030, yet most OEMs still struggle to monetize software. Without a clear GTM and sales approach, digital products risk remaining side projects instead of revenue drivers.
Bringing digital products to market requires a new commercial mindset. Many OEMs face hurdles that prevent traction and adoption:
I help OEMs transform digital initiatives into scalable revenue streams. My approach combines structured strategy and hands-on execution:
At Clustermarket, we scaled SaaS adoption in more than 1,800 labs worldwide, including pharma, biotech innovators, and academic/government labs. I worked with OEM partners to embed SaaS into their sales workflows, helping traditional hardware companies unlock digital revenue streams.